A citation-based method for searching scientific literature

Niels J Brouwer, Robert M Verdijk, Steffen Heegaard, Marina Marinkovic, Bita Esmaeli, Martine J Jager. Prog Retin Eye Res 2022
Times Cited: 10







List of co-cited articles
112 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Immunotherapy With Programmed Cell Death 1 Inhibitors for 5 Patients With Conjunctival Melanoma.
Oded Sagiv, Sudip D Thakar, Thomas J Kandl, Joshua Ford, Matthew C Sniegowski, Wen-Jen Hwu, Bita Esmaeli. JAMA Ophthalmol 2018
48
60

Conjunctival melanoma in the Netherlands: a nationwide study.
Guy S Missotten, Sander Keijser, Rob J W De Keizer, Didi De Wolff-Rouendaal. Invest Ophthalmol Vis Sci 2005
136
60

Conjunctival melanomas harbor BRAF and NRAS mutations and copy number changes similar to cutaneous and mucosal melanomas.
Klaus G Griewank, Henrike Westekemper, Rajmohan Murali, Monika Mach, Bastian Schilling, Thomas Wiesner, Tobias Schimming, Elisabeth Livingstone, Antje Sucker, Florian Grabellus,[...]. Clin Cancer Res 2013
134
60

BRAF mutations in conjunctival melanoma: investigation of incidence, clinicopathological features, prognosis and paired premalignant lesions.
Ann-Cathrine Larsen, Christina Dahl, Christina M Dahmcke, Johanne Lade-Keller, Volkert D Siersma, Peter B Toft, Sarah E Coupland, Jan U Prause, Per Guldberg, Steffen Heegaard. Acta Ophthalmol 2016
60
60

Conjunctival melanoma treatment outcomes in 288 patients: a multicentre international data-sharing study.
Puneet Jain, Paul T Finger, Maria Fili, Bertil Damato, Sarah E Coupland, Heinrich Heimann, Nihal Kenawy, Niels J Brouwer, Marina Marinkovic, Sjoerd G Van Duinen,[...]. Br J Ophthalmol 2021
12
50


NF1 mutations in conjunctival melanoma.
S L Scholz, I Cosgarea, D Süßkind, R Murali, I Möller, H Reis, S Leonardelli, B Schilling, T Schimming, E Hadaschik,[...]. Br J Cancer 2018
44
50

Conjunctival Melanoma Targeted Therapy: MAPK and PI3K/mTOR Pathways Inhibition.
Ikram El Zaoui, Maya Bucher, Donata Rimoldi, Michael Nicolas, Gurkan Kaya, Rosanna Pescini Gobert, Nicola Bedoni, Ann Schalenbourg, Ezziat Sakina, Leonidas Zografos,[...]. Invest Ophthalmol Vis Sci 2019
18
50

Conjunctival melanoma: outcomes based on tumor origin in 382 consecutive cases.
Carol L Shields, Jeremy S Markowitz, Irina Belinsky, Hal Schwartzstein, Nina S George, Sara E Lally, Arman Mashayekhi, Jerry A Shields. Ophthalmology 2011
131
50

Conjunctival melanoma: is it increasing in the United States?
Guo-Pei Yu, Dan-Nin Hu, Steven McCormick, Paul T Finger. Am J Ophthalmol 2003
134
50

Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma.
Georgina V Long, Axel Hauschild, Mario Santinami, Victoria Atkinson, Mario Mandalà, Vanna Chiarion-Sileni, James Larkin, Marta Nyakas, Caroline Dutriaux, Andrew Haydon,[...]. N Engl J Med 2017
790
40

Conjunctival Melanoma: Current Treatments and Future Options.
Joseph M Grimes, Nirav V Shah, Faramarz H Samie, Richard D Carvajal, Brian P Marr. Am J Clin Dermatol 2020
16
40

Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients.
C L Shields, J A Shields, K Gündüz, J Cater, G V Mercado, N Gross, B Lally. Arch Ophthalmol 2000
215
40

Incidence trends of conjunctival malignant melanoma in Canada.
Feras M Ghazawi, Rami Darwich, Michelle Le, Abdulhadi Jfri, Elham Rahme, Julia Valdemarin Burnier, Denis Sasseville, Miguel N Burnier, Ivan V Litvinov. Br J Ophthalmol 2020
20
40


TERT promoter mutations in ocular melanoma distinguish between conjunctival and uveal tumours.
K G Griewank, R Murali, B Schilling, S Scholz, A Sucker, M Song, D Süsskind, F Grabellus, L Zimmer, U Hillen,[...]. Br J Cancer 2013
85
40

Time trends in the incidence of conjunctival melanoma in Sweden.
E Triay, L Bergman, B Nilsson, C All-Ericsson, S Seregard. Br J Ophthalmol 2009
83
40

Improved survival with ipilimumab in patients with metastatic melanoma.
F Stephen Hodi, Steven J O'Day, David F McDermott, Robert W Weber, Jeffrey A Sosman, John B Haanen, Rene Gonzalez, Caroline Robert, Dirk Schadendorf, Jessica C Hassel,[...]. N Engl J Med 2010
40

Population-based assessment of clinical characteristics predicting outcome of conjunctival melanoma in whites.
Seppo Tuomaala, Sebastian Eskelin, Ahti Tarkkanen, Tero Kivelä. Invest Ophthalmol Vis Sci 2002
128
40

Greater Tumor Thickness, Ulceration, and Positive Sentinel Lymph Node Are Associated With Worse Prognosis in Patients With Conjunctival Melanoma: Implications for Future AJCC Classifications.
Bita Esmaeli, Maria Laura Rubin, Shiqiong Xu, Ryan P Goepfert, Jonathan L Curry, Victor G Prieto, Jing Ning, Michael T Tetzlaff. Am J Surg Pathol 2019
18
40

KIT as a therapeutic target in metastatic melanoma.
Richard D Carvajal, Cristina R Antonescu, Jedd D Wolchok, Paul B Chapman, Ruth-Ann Roman, Jerrold Teitcher, Katherine S Panageas, Klaus J Busam, Bartosz Chmielowski, Jose Lutzky,[...]. JAMA 2011
570
30

Somatic activation of KIT in distinct subtypes of melanoma.
John A Curtin, Klaus Busam, Daniel Pinkel, Boris C Bastian. J Clin Oncol 2006
30

Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF-mutant melanoma (COLUMBUS): a multicentre, open-label, randomised phase 3 trial.
Reinhard Dummer, Paolo A Ascierto, Helen J Gogas, Ana Arance, Mario Mandala, Gabriella Liszkay, Claus Garbe, Dirk Schadendorf, Ivana Krajsova, Ralf Gutzmer,[...]. Lancet Oncol 2018
468
30

Systemic Treatment of Metastatic Conjunctival Melanoma.
Simão Pinto Torres, Teresa André, Emanuel Gouveia, Lívio Costa, Maria José Passos. Case Rep Oncol Med 2017
23
30


KIT gene mutations and copy number in melanoma subtypes.
Carol Beadling, Erick Jacobson-Dunlop, F Stephen Hodi, Claudia Le, Andrea Warrick, Janice Patterson, Ajia Town, Amy Harlow, Frank Cruz, Sharl Azar,[...]. Clin Cancer Res 2008
458
30

Conjunctival Melanoma Responsive to Combined Systemic BRAF/MEK Inhibitors.
Lora R Dagi Glass, Donald P Lawrence, Frederick A Jakobiec, Suzanne K Freitag. Ophthalmic Plast Reconstr Surg 2017
23
30

Definition of Biologically Distinct Groups of Conjunctival Melanomas According to Etiological Factors and Implications for Precision Medicine.
Sophie Gardrat, Alexandre Houy, Kelly Brooks, Nathalie Cassoux, Raymond Barnhill, Stéphane Dayot, Ivan Bièche, Virginie Raynal, Sylvain Baulande, Richard Marais,[...]. Cancers (Basel) 2021
6
50

Incidence of noncutaneous melanomas in the U.S.
Colleen C McLaughlin, Xiao-Cheng Wu, Ahmedin Jemal, Howard J Martin, Lisa M Roche, Vivien W Chen. Cancer 2005
412
30


Eye-Sparing Treatment for Diffuse Invasive Conjunctival Melanoma.
Leandro J Chaves, Bradley Huth, James J Augsburger, Zelia M Correa. Ocul Oncol Pathol 2018
10
30

Treatment of conjunctival melanoma in a Dutch referral centre.
Niels J Brouwer, Marina Marinkovic, Sjoerd G van Duinen, Jaco C Bleeker, Martine J Jager, Gregorius P M Luyten. Br J Ophthalmol 2018
27
30

PD-L1/PD-1 expression and tumor-infiltrating lymphocytes in conjunctival melanoma.
Jinfeng Cao, Niels J Brouwer, Kate E Richards, Marina Marinkovic, Sjoerd van Duinen, Daan Hurkmans, Els M E Verdegaal, Ekaterina S Jordanova, Martine J Jager. Oncotarget 2017
28
30

A Retrospective Review of Conjunctival Melanoma Presentation, Treatment, and Outcome and an Investigation of Features Associated With BRAF Mutations.
Ann-Cathrine Larsen, Christina M Dahmcke, Christina Dahl, Volkert D Siersma, Peter B Toft, Sarah E Coupland, Jan U Prause, Per Guldberg, Steffen Heegaard. JAMA Ophthalmol 2015
62
30

Immune Checkpoint Inhibitor Therapy as an Eye-Preserving Treatment for Locally Advanced Conjunctival Melanoma.
Bennett Yau-Bun Hong, Joshua R Ford, Isabella C Glitza, Carlos A Torres Cabala, Michael Tetzlaff, Victor G Prieto, Richard Parker, Claire Daniel, Bita Esmaeli. Ophthalmic Plast Reconstr Surg 2021
5
60

Conjunctival Melanoma - Epidemiological Trends and Features.
Snježana Kaštelan, Antonela Gverović Antunica, Lidija Beketić Orešković, Jasminka Salopek Rabatić, Boris Kasun, Ivana Bakija. Pathol Oncol Res 2018
30
30

Conjunctival melanoma.
S Seregard. Surv Ophthalmol 1998
156
30

Genomic and transcriptomic landscape of conjunctival melanoma.
Katarina Cisarova, Marc Folcher, Ikram El Zaoui, Rosanna Pescini-Gobert, Virginie G Peter, Beryl Royer-Bertrand, Leonidas Zografos, Ann Schalenbourg, Michael Nicolas, Donata Rimoldi,[...]. PLoS Genet 2020
13
30

Molecular Genetics of Conjunctival Melanoma and Prognostic Value of TERT Promoter Mutation Analysis.
Natasha M van Poppelen, Jolique A van Ipenburg, Quincy van den Bosch, Jolanda Vaarwater, Tom Brands, Bert Eussen, Frank Magielsen, Hendrikus J Dubbink, Dion Paridaens, Erwin Brosens,[...]. Int J Mol Sci 2021
5
60

Incidence and Survival of Patients With Conjunctival Melanoma in Europe.
Gianni Virgili, Mariacristina Parravano, Gemma Gatta, Riccardo Capocaccia, Cinzia Mazzini, Sandra Mallone, Laura Botta. JAMA Ophthalmol 2020
11
30

Conjunctival melanoma copy number alterations and correlation with mutation status, tumor features, and clinical outcome.
Nihal Kenawy, Helen Kalirai, Joseph J Sacco, Sarah L Lake, Steffen Heegaard, Ann-Cathrine Larsen, Paul T Finger, Tatyana Milman, Kimberly Chin, Carlo Mosci,[...]. Pigment Cell Melanoma Res 2019
32
30

Molecular Characteristics of Conjunctival Melanoma Using Whole-Exome Sequencing.
Swarup S Swaminathan, Matthew G Field, David Sant, Gaofeng Wang, Anat Galor, Sander R Dubovy, J William Harbour, Carol L Karp. JAMA Ophthalmol 2017
31
30

Targeting of the MAPK and AKT pathways in conjunctival melanoma shows potential synergy.
Jinfeng Cao, Renier C Heijkants, Aart G Jochemsen, Mehmet Dogrusöz, Mark J de Lange, Pieter A van der Velden, Sjoerd H van der Burg, Martine J Jager, Robert M Verdijk. Oncotarget 2016
39
30

Advances in the management of conjunctival melanoma.
Gargi K Vora, Hakan Demirci, Brian Marr, Prithvi Mruthyunjaya. Surv Ophthalmol 2017
57
30

Combined vemurafenib and cobimetinib in BRAF-mutated melanoma.
James Larkin, Paolo A Ascierto, Brigitte Dréno, Victoria Atkinson, Gabriella Liszkay, Michele Maio, Mario Mandalà, Lev Demidov, Daniil Stroyakovskiy, Luc Thomas,[...]. N Engl J Med 2014
30


Histologic features of conjunctival melanoma predictive of metastasis and death (an American Ophthalmological thesis).
Bita Esmaeli, Dianna Roberts, Merrick Ross, Melissa Fellman, Hilda Cruz, Stella K Kim, Victor G Prieto. Trans Am Ophthalmol Soc 2012
27
30

Multicenter, International Assessment of the Eighth Edition of the American Joint Committee on Cancer Cancer Staging Manual for Conjunctival Melanoma.
Puneet Jain, Paul T Finger, Bertil Damato, Sarah E Coupland, Heinrich Heimann, Nihal Kenawy, Niels J Brouwer, Marina Marinkovic, Sjoerd G Van Duinen, Jean Pierre Caujolle,[...]. JAMA Ophthalmol 2019
24
30

The mutational constraint spectrum quantified from variation in 141,456 humans.
Konrad J Karczewski, Laurent C Francioli, Grace Tiao, Beryl B Cummings, Jessica Alföldi, Qingbo Wang, Ryan L Collins, Kristen M Laricchia, Andrea Ganna, Daniel P Birnbaum,[...]. Nature 2020
20



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.